- Home
- NDRA vs GNLN Comparison
NDRA vs GNLN Comparison
Compare NDRA & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- GNLN
- Stock Information
- Founded
- NDRA 2007
- GNLN 2005
- Country
- NDRA United States
- GNLN United States
- Employees
- NDRA N/A
- GNLN N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GNLN Durable Goods
- Sector
- NDRA Health Care
- GNLN Consumer Discretionary
- Exchange
- NDRA Nasdaq
- GNLN Nasdaq
- Market Cap
- NDRA 1.7M
- GNLN 2.0M
- IPO Year
- NDRA 2017
- GNLN 2019
- Fundamental
- Price
- NDRA $3.23
- GNLN $0.01
- Analyst Decision
- NDRA Strong Buy
- GNLN
- Analyst Count
- NDRA 1
- GNLN 0
- Target Price
- NDRA $50.00
- GNLN N/A
- AVG Volume (30 Days)
- NDRA 312.7K
- GNLN 270.8M
- Earning Date
- NDRA 05-15-2025
- GNLN 05-15-2025
- Dividend Yield
- NDRA N/A
- GNLN N/A
- EPS Growth
- NDRA N/A
- GNLN N/A
- EPS
- NDRA N/A
- GNLN N/A
- Revenue
- NDRA N/A
- GNLN $13,275,000.00
- Revenue This Year
- NDRA N/A
- GNLN $1,541.21
- Revenue Next Year
- NDRA N/A
- GNLN N/A
- P/E Ratio
- NDRA N/A
- GNLN N/A
- Revenue Growth
- NDRA N/A
- GNLN N/A
- 52 Week Low
- NDRA $2.97
- GNLN $0.01
- 52 Week High
- NDRA $602.00
- GNLN $21.80
- Technical
- Relative Strength Index (RSI)
- NDRA 40.85
- GNLN 19.03
- Support Level
- NDRA $2.90
- GNLN $0.01
- Resistance Level
- NDRA $6.89
- GNLN $0.01
- Average True Range (ATR)
- NDRA 0.98
- GNLN 0.00
- MACD
- NDRA -0.31
- GNLN 0.01
- Stochastic Oscillator
- NDRA 7.17
- GNLN 15.00
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.